Clinical Trial Detail

NCT ID NCT01744652
Title Dasatinib and Crizotinib in Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements yes
Sponsors M.D. Anderson Cancer Center
Indications

lymphoma

Advanced Solid Tumor

Therapies

Crizotinib + Dasatinib

Age Groups: adult senior

Additional content available in CKB BOOST